We are live on
!
Find out more
Amphastar Pharmaceuticals
AMPH
AMPH
135 hedge funds and large institutions have $476M invested in Amphastar Pharmaceuticals in 2021 Q1 according to their latest regulatory filings, with 20 funds opening new positions, 43 increasing their positions, 51 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
54% more first-time investments, than exits
New positions opened: 20 | Existing positions closed: 13
5% more funds holding
Funds holding: 129 → 135 (+6)
0.17% more ownership
Funds ownership: 54.73% → 54.89% (+0.17%)
9% less capital invested
Capital invested by funds: $522M → $476M (-$46.4M)
16% less repeat investments, than reductions
Existing positions increased: 43 | Existing positions reduced: 51
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $429K
Holders
135
Holders Change
+6
Holders Change %
+4.65%
% of All Funds
2.37%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
20
Increased
43
Reduced
51
Closed
13
Calls
–
Puts
$429K
Net Calls
-$429K
Net Calls Change
-$429K
Top Buyers
| 1 |
BlackRock
New York
|
+$4.33M |
| 2 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
+$4.01M |
| 3 |
Goldman Sachs
New York
|
+$3.09M |
| 4 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
+$2.98M |
| 5 |
State Street
Boston,
Massachusetts
|
+$2.26M |
